|Stanford University, School of Medicine, Department of radiation oncology|
|University of California, Davis (UCD), PhD|
|Stanford University, School of Medicine, MD|
|University of California, Berkeley, BA|
Dr. Susan Knox is co-founder of RadioRx.
Dr. Knox is an associate professor at Stanford University School of Medicine in the department of radiation oncology. Within the school of medicine, she is part of the training programs in cancer biology, immunology and molecular pharmacology, as well as an advising dean. Dr. Knox is also a member of the Stanford University Bio X program and Comprehensive Cancer Center. At the Cancer Center, she is a physician in the clinical department of radiation oncology, a member of the cancer biology and experimental therapeutics programs, director of the protocol review and monitoring system, and chair of the data and safety monitoring committee. In addition, Dr. Knox has published over 100 peer-reviewed scientific articles focused on radiation oncology, radiobiology, targeted therapies and novel radiosensitizers. She has filed six patents and has received national awards and recognition for research.
In addition, she was on the selection committee for the Charles F. Kettering Award from the General Motors Cancer Research Foundation, and was named a Lazard Faculty Scholar.
Dr. Knox has served on numerous educational, scientific and translational medicine committees within national and international organizations/societies, in addition to editorial boards for several academic journals. Dr. Knox brings more than 20 years of experience working in the medical field, focusing on radiation oncology and translational medicine.